ClassID:

20571

A61K31/787 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Synthetic polymeric materials; Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom

Sub-classes:
Recent Application in this class:
#1
20260137714
2026-05-21

METHODS AND COMPOSITIONS FOR TREATMENT OF OPHTHALMIC DISEASE

#2
20260053846
2026-02-26

METHODS AND COMPOSITIONS FOR TREATMENT OF AMYLOID-RELATED DISORDERS

#3
20250268931
2025-08-28

TRANSCRIPTIONAL INHIBITOR FOR IMMUNE-RELATED GENE

#4
20250152619
2025-05-15

POLYIMIDAZOLIUM-BASED CATIONIC ANTIMICROBIAL POLYMERS FOR NOVEL MASTITIS PROPHYLACTIC SOLUTIONS

#5
20250115715
2025-04-10

POLYMER COMPOUNDS AND COMPOSITION FOR NUCLEIC ACID DELIVERY COMPRISING THE SAME

#6
20250092070
2025-03-20

DEGRADABLE POLYMERS OF A CYCLIC SILYL ETHER AND USES THEREOF

#7
20250057874
2025-02-20

SYNTHETIC MELANIN NANOPARTICLES AND USES THEREOF

#8
20250026880
2025-01-23

POLY(DIALLYLDIMETHYLAMMONIUM) FLUORIDE - A NEW ANTI-CARIES AND REMINERALIZING AGENT

#9
20240316189
2024-09-26

METHODS FOR PREPARING COMPLEX FOR ENHANCING IMMUNE RESPONSE

#10
20240294555
2024-09-05

DEGRADABLE POLYMERS OF A CYCLIC SILYL ETHER AND USES THEREOF

#11
20240254127
2024-08-01

TEMOZOLOMIDE COMPOUNDS, POLYMERS PREPARED THEREFROM, AND METHOD OF TREATING A DISEASE

#12
20240124476
2024-04-18

MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME

#13
20240110004
2024-04-04

HUNTINGTIN MIMETIC PROTEIN-LIKE POLYMERS AND USES THEREOF

#14
20240066052
2024-02-29

BIODEGRADABLE LUNG SEALANTS

#15
20240009228
2024-01-11

PEGYLATED RAPAMYCIN COMPOUND AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#16
20230416468
2023-12-28

BIOACTIVE POLYETHYLENE COPOLYMER, POLYETHYLENE MACROMOLECULE AND RELATED METHODS THEREOF

#17
20230248759
2023-08-10

ORAL RINSE COMPOSITIONS FOR ALLEVIATING XEROSTOMIA COMPRISING POLYETHYLENE GLYCOL DERIVATIVES

#18
20230241057
2023-08-03

COMPOUNDS FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF THROMBI

#19
20230210893
2023-07-06

Methods for preparing complex for enhancing immune response

#20
20230135752
2023-05-04

MEDICAMENT FOR KILLING TUMOR CELLS

#21
20230131111
2023-04-27

BIODEGRADABLE POLYIMIDAZOLIUMS AND OLIGOIMIDAZOLIUMS

#22
20230102864
2023-03-30

POLYMERS, COMPOSITIONS AND METHODS FOR TREATING HYPERURICEMIA

#23
20230085942
2023-03-23

POLYMERS, COMPOSITIONS AND METHODS FOR TREATING HYPERURICEMIA

#24
20220347206
2022-11-03

METHODS OF PROPHYLAXIS AND TREATMENT OF COVID-19 USING AZOXIMER BROMIDE

#25
20220332892
2022-10-20

Beta-peptido sugar-copolymer

#26
20220280514
2022-09-08

METHODS OF TREATING BILE ACID DIARRHEA

#27
20220184115
2022-06-16

Polymer nanoparticle, polymer composition, method of making a polymer nanoparticle, method for treatment of bacterial biofilms, and method for detection of bacterial biofilms

#28
20220184111
2022-06-16

METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY

#29
20220072124
2022-03-10

Complex for enhancing immune response

#30
20220002250
2022-01-06

Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms for therapeutic use in treating diseases in animals, fish or humans

#31
20210393673
2021-12-23

Synthetic melanin nanoparticles and uses thereof

#32
20210393572
2021-12-23

PHARMACEUTICALLY ACTIVE CANNABIS-BASED COMPOSITIONS AND METHODS OF USE FOR TREATING GASTROINTESTINAL CONDITIONS

#33
20210386832
2021-12-16

Pharmaceutical Compositions And Methods

#34
20210379099
2021-12-09

CUCURBITURIL MOLECULAR CONTAINERS AND METHODS OF USING SAME

#35
20210379014
2021-12-09

PHARMACEUTICAL COMPOSITIONS AND METHODS

#36
20210284664
2021-09-16

Degradable polymers of a cyclic silyl ether and uses thereof

#37
20210277158
2021-09-09

Molecular imprinted polymers targeting phenylalanine

#38
20210275718
2021-09-09

Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices

#39
20210268016
2021-09-02

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID-RELATED DISORDERS

#40
20210206774
2021-07-08

Molecular containers and methods of making and using same

#41
20210198265
2021-07-01

Temozolomide compounds, polymers prepared therefrom, and method of treating a disease

#42
20210106612
2021-04-15

TARGET GENE TRANSCRIPTIONAL REPRESSION INHIBITOR THAT CAN BE DESIGNED IN A SEQUENCE-SPECIFIC MANNER, COMPOSITION CONTAINING SAME, AND USE THEREOF

#43
20210093749
2021-04-01

Bioactive polymer for bone regeneration

#44
20210040265
2021-02-11

Chemical compositions with antimicrobial functionality

#45
20210023211
2021-01-28

Combination of anti-FGFR4-antibody and bile acid sequestrant

#46
20210022743
2021-01-28

IN VIVO CROSSLINKING OF EMBOLIC HYDROGELS USING BIOORTHOGONAL CLICK CHEMISTRY

#47
20200368270
2020-11-26

BRANCHED POLYAMINO ACID BACTERIOSTATIC AGENT AND APPLICATION THEREOF

#48
20200254067
2020-08-13

Pharmaceutical compositions and methods

#49
20200247930
2020-08-06

DMA-CO-TEMPO POLYMER FOR THERAPEUTIC ROS SCAVENGING

#50
20200140591
2020-05-07

Molecular imprinted polymers targeting phenylalanine

#51
20200140448
2020-05-07

Temozolomide compounds, polymers prepared therefrom, and method of treating a disease

#52
20200113934
2020-04-16

Synthetic melanin nanoparticles and uses thereof

#53
20200108049
2020-04-09

Pharmaceutical compositions and methods

#54
20200055879
2020-02-20

Degradable polymers of a cyclic silyl ether and uses thereof

#55
20200046760
2020-02-13

Antimicrobial poly(alkylated imidazolium) salts

#56
20190359769
2019-11-28

PHARMACEUTICAL AGENT FOR IRON CHELATING

#57
20190343873
2019-11-14

SEQUENCE-SELECTIVE GENE EXPRESSION REGULATORS

#58
20190275117
2019-09-12

Pharmaceutical compositions and methods

#59
20190262457
2019-08-29

NOVEL ALKYLATING AGENT

#60
20190255182
2019-08-22

CTB-PI polyamide conjugate for activating expression of specific gene

#61
20190247425
2019-08-15

RUNX inhibitor

#62
20190201378
2019-07-04

Pharmaceutical compositions and methods

#63
20190177479
2019-06-13

Chemical compositions with antimicrobial functionality

#64
20190175642
2019-06-13

Polymer nanoparticle, polymer composition, method of making a polymer nanoparticle, method for treatment of bacterial biofilms, and method for detection of bacterial biofilms

#65
20190169342
2019-06-06

POLYIMIDAZOLES FOR USE AS BILE ACID SEQUESTRANTS

#66
20190169126
2019-06-06

Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms

#67
20190161579
2019-05-30

Method to make fluorescent nanodots for fast bacteria staining and broad spectrum antimicrobial applications

#68
20190151452
2019-05-23

Polymers including active agents

#69
20190133125
2019-05-09

ANTIMICROBIAL POLYMER

#70
20190030067
2019-01-31

Core-to-surface polymerization for the synthesis of star polymers and uses thereof

#71
20190001018
2019-01-03

Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices

#72
20180353536
2018-12-13

Sachet Formulation for Amine Polymers

#73
20180346804
2018-12-06

Crosslinked polymers derived from monomers having acryloyl and lactam moieties and sulfonic acid/sulfonate comonomers, compositions thereof, and applications thereof

#74
20180344815
2018-12-06

Method for producing hyaluronidase conjugate with polyethylenepiperazine derivatives and the use of the conjugate produced

#75
20180296459
2018-10-18

COMPOSITIONS CONTAINING POLYMERIC, IONIC COMPOUNDS COMPRISING IMIDAZOLIUM GROUPS

#76
20180280524
2018-10-04

Polymer conjugate vaccines

#77
20180243469
2018-08-30

BIOACTIVE POLYMER FOR BONE REGENERATION

#78
20180221495
2018-08-09

ACTIVE PRINCIPLE FOR MITIGATING UNDESIRED MEDICAL CONDITIONS

#79
20180161364
2018-06-14

CATIONIC COMPOUNDS AND THEIR USE AS ANTIMYCOTIC AND ANTIMICROBIAL AGENTS

#80
20180133312
2018-05-17

Combination of anti-FGFR4-antibody and bile acid sequestrant

#81
20180092845
2018-04-05

ENZYME-RESPONSIVE NANOPARTICLES

#82
20180079754
2018-03-22

Temozolomide compounds, polymers prepared therefrom, and method of treating a disease

#83
20180009940
2018-01-11

Macromolecular transition metal complexes for treatment of cancer and process for their preparation

#84
20180000858
2018-01-04

Rapid-deposition thin-film forming compositions as effective wound care treatment

#85
20170368377
2017-12-28

Photoluminescent panthenol citrate biomaterials

#86
20170326172
2017-11-16

Sachet Formulation for Amine Polymers

#87
20170296577
2017-10-19

Multi-dose compositions containing an antimicrobial polyamide or octenidine preservative

#88
20170296511
2017-10-19

Methods for treating and preventing ocular diseases, disorders, and conditions with melanin and melanin analogs, precursors, and derivatives

#89
20170274051
2017-09-28

Pharmaceutical compositions and methods

#90
20170182087
2017-06-29

MAIN CHAIN POLYAMINES

#91
20170073471
2017-03-16

Condensation polymers for antimicrobial applications

#92
20170071912
2017-03-16

Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases

#93
20170056371
2017-03-02

Pharmaceutical compositions and methods

#94
20170049924
2017-02-23

Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices

#95
20170037013
2017-02-09

Antifungal compound

#96
20170014532
2017-01-19

Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof

#97
20170000818
2017-01-05

Nylon-3 polymers active against

#98
20160375093
2016-12-29

Pharmaceutical compositions and methods

#99
20160326319
2016-11-10

Condensation polymers for antimicrobial applications

#100
20160312385
2016-10-27

Nanofibers Containing Photocurable Ester Derivative of Hyaluronic Acid or Its Salt, Photocured Nanofibers, Method of Synthesis Thereof, Preparation Containing Photocured Nanofibers and Use Thereof

#101
20160286809
2016-10-06

Synthesis of pure diallyl morpholinium monomers in high yields and using antibacterial effect of their spiro polymers

#102
20160279164
2016-09-29

High-Molecular Weight Conjugate Of Resorcinol Derivatives

#103
20160271165
2016-09-22

POLYLNOSINIC-POLYCYTIDYLIC ACID (POLY (I:C)) FORMULATIONS FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS

#104
20160263198
2016-09-15

Pharmaceutical compositions and methods

#105
20160263149
2016-09-15

Pharmaceutical compositions and methods

#106
20160263148
2016-09-15

Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders

#107
20160208046
2016-07-21

Amine functional polyamides

#108
20160177019
2016-06-23

Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes

#109
20160175451
2016-06-23

Active principle for mitigating undesired medical conditions

#110
20160113961
2016-04-28

Sachet formulation for amine polymers

#111
20160045532
2016-02-18

Methods for modulating chemotherapeutic cytotoxicity

#112
20150366900
2015-12-24

Conductive biomaterial for enhancement of conduction in vitro and in vivo

#113
20150306227
2015-10-29

Polymer filaments including pharmaceutical agents and delivering same

#114
20150306135
2015-10-29

Oral pharmaceutical composition for drugs with a high-dosage regimen

#115
20150290279
2015-10-15

Pharmaceutical compositions and methods

#116
20150238521
2015-08-27

Nanoparticle compositions of antibacterial compounds and other uses thereof

#117
20150203454
2015-07-23

Antifungal compound

#118
20150191571
2015-07-09

Polyamide compound and pharmaceutical composition for treating mitochondrial genetic disease

#119
20150118310
2015-04-30

Organic-inorganic hybrid composite of polymerized nitroxide compound and inorganic particles

#120
20150086501
2015-03-26

Polymers functionalized with ion-specific recognition elements

#121
20150010650
2015-01-08

Method of treating traumatic brain or spinal cord injury with biomembrane sealing agent and magnesium compounds

#122
20140348772
2014-11-27

PRODUCTION OF HYDROGELS BY MEANS OF DIELS-ALDER REACTION

#123
20140287038
2014-09-25

Orally effective methylphenidate extended release powder and aqueous suspension product

#124
20140275469
2014-09-18

Amine functional polyamides

#125
20140271526
2014-09-18

Antimicrobial polyamide compositions and mastitis treatment

#126
20140120146
2014-05-01

Medical antimicrobial composition and medical device comprising the same

#127
20140099269
2014-04-10

Chewing gum having sustained release of nicotine

#128
20140094529
2014-04-03

Molecular containers and methods of making and using same

#129
20140004160
2014-01-02

Orally effective methylphenidate extended release powder and aqueous suspension product

#130
20130345273
2013-12-26

Reversal of drug-induced neuromuscular block using novel molecular containers

#131
20130337033
2013-12-19

Nitric oxide-releasing compositions and methods

#132
20130189215
2013-07-25

POLYIMIDAZOLES FOR USE AS BILE ACID SEQUESTRANTS

#133
20130183263
2013-07-18

PHARMACEUTICAL COMPOSITIONS AND METHODS

#134
20130171205
2013-07-04

Nanocell Drug Delivery System

#135
20130156720
2013-06-20

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLIC SYNDROME AND RELATED DISEASES AND DISORDERS

#136
20130108558
2013-05-02

Formulation comprising nicotine and a cation exchange resin

#137
20130064848
2013-03-14

Heterochain aliphatic poly-N-oxide copolymers and vaccinating agents and drugs based thereon

#138
20130052156
2013-02-28

ANTIVIRAL METHOD

#139
20130039878
2013-02-14

Triple cross-linked collagen, method of manufacturing the same, and use thereof

#140
20130011343
2013-01-10

Chewing gum having sustained release of nicotine

#141
20130004571
2013-01-03

Orally effective methylphenidate extended release powder and aqueous suspension product

#142
20120289535
2012-11-15

Dual phase drug release system

#143
20120276040
2012-11-01

ANTIMICROBIAL COMPOSITIONS AND METHODS OF MAKING SAME

#144
20120244095
2012-09-27

Compositions containing polymeric, ionic compounds comprising imidazolium groups

#145
20120207824
2012-08-16

Orally effective methylphenidate extended release powder and aqueous suspension product

#146
20120134952
2012-05-31

Antiviral method

#147
20120094932
2012-04-19

Macrocyclic lactone compounds and methods for their use

#148
20120093891
2012-04-19

Macrocyclic lactone compounds and methods for their use

#149
20120093722
2012-04-19

Synthetic diblock copolypeptide hydrogels for use in the central nervous system

#150
20120071628
2012-03-22

TOPICAL THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES COMPRISING COMPOUND CAPABLE OF BINDING SPECIFICALLY TO DNA SEQUENCE

#151
20120070382
2012-03-22

Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof

#152
20120016015
2012-01-19

Aldehyde conjugated flavonoid preparations

#153
20120004255
2012-01-05

Dual phase drug release system

#154
20110268809
2011-11-03

Nicotine-Containing Pharmaceutical Compositions

#155
20110135733
2011-06-09

Aldehyde conjugated flavonoid preparations

#156
20110097364
2011-04-28

MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE

#157
20110085979
2011-04-14

Conjugate of a polymer, an anti-angiogenesis agent and a targeting moiety, and uses thereof in the treatment of bone related angiogenesis conditions

#158
20110059010
2011-03-10

Dual phase drug release system

#159
20110046070
2011-02-24

GENE EXPRESSION INHIBITOR SELECTIVE FOR MATRIX METALLOPROTEINASE-9 GENE

#160
20110008403
2011-01-13

Medical antimicrobial composition and medical device comprising the same

#161
20100316721
2010-12-16

Granular sustained release preparation and production thereof

#162
20100303912
2010-12-02

Nanocell Drug Delivery System

#163
20100179156
2010-07-15

Antimicrobial compositions

#164
20100158812
2010-06-24

Anti-cancer medicine both for diagnosing and treating cancer

#165
20100129308
2010-05-27

Polymers functionalized with ion-specific recognition elements

#166
20100069579
2010-03-18

Activated polyoxazolines and compositions comprising the same

#167
20100055066
2010-03-04

Agent for prophylactic and/or therapeutic treatment of diabetes

#168
20100029849
2010-02-04

High molecular weight derivative of nucleic acid antimetabolite

#169
20100003338
2010-01-07

Micelles for delivery of nitric oxide

#170
20090304623
2009-12-10

Once A Day Formulation for Phosphate Binders

#171
20090281300
2009-11-12

High-molecular weight derivative of nucleic acid antimetabolite

#172
20090239782
2009-09-24

High-molecular weight conjugate of resorcinol derivatives

#173
20090220615
2009-09-03

Main chain acid-degradable polymers for the delivery of bioactive materials

#174
20090220607
2009-09-03

POLYMERIC COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF

#175
20090196847
2009-08-06

Quaternary ammonium functionalized glycodendrimers, methods for the production and use thereof

#176
20090155201
2009-06-18

Alkylated poly(allylamine) polymers and methods of use

#177
20090143226
2009-06-04

Adsorbents for advanced glycation endproducts

#178
20090137606
2009-05-28

Chewable formulations

#179
20090110655
2009-04-30

Prophylactic and/or therapeutic drug for nonalcoholic steatohepatitis

#180
20090081152
2009-03-26

ANTIMICROBIAL COMPOSITIONS AND METHODS OF MAKING SAME

#181
20090047233
2009-02-19

Method for removing phosphate and polymer used therefore

#182
20080317701
2008-12-25

Phosphate Ion Adsorbent

#183
20080295188
2008-11-27

Method of screening for substances which proliferate natural killer cells

#184
20080287365
2008-11-20

Method for proliferating natural killer cells

#185
20080247987
2008-10-09

Block Copolymer Compositions and Uses Thereof

#186
20080138375
2008-06-12

Macrocyclic lactone compounds and methods for their use

#187
20080102052
2008-05-01

Aldehyde conjugated flavonoid preparations

#188
20080057113
2008-03-06

Pharmaceutical Anti-Herpetic Composition, Method for Producing a Dosage Form Based Thereon and Method for the Use Thereof

#189
20070286841
2007-12-13

Method for lowering serum glucose

#190
20070259040
2007-11-08

Novel triptan formulations and methods for making them

#191
20070258938
2007-11-08

Method of treating neuronal injury by administering magnesium chloride and PEG

#192
20070248566
2007-10-25

Antimicrobial polyisocyanate and derivatives thereof

#193
20070231291
2007-10-04

Polymeric anti-microbial agents

#194
20070212325
2007-09-13

Insulin Resistance-Improving Agent

#195
20070196454
2007-08-23

Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices

#196
20070191562
2007-08-16

Composition comprising a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound, a polymer containing said monomer compound and the use thereof

#197
20070190021
2007-08-16

Poly(diallylamine)-based bile acid sequestrants

#198
20070190018
2007-08-16

Dual phase drug release system

#199
20070184013
2007-08-09

Antiviral method

#200
20070155950
2007-07-05

Alkylated poly(allylamine) polymers and methods of use

#201
20070154457
2007-07-05

Use of eIF-5A to kill multiple myeloma cells

#202
20070116675
2007-05-24

Drug and method for proliferating natural killer cells

#203
20070086973
2007-04-19

Drug delivery systems for photodynamic therapy

#204
20070059277
2007-03-15

Sachet formulation for amine polymers

#205
20070041934
2007-02-22

Dendrimer based compositions and methods of using the same

#206
20070041901
2007-02-22

Stabilized aptamers to PSMA and their use as prostate cancer therapeutics

#207
20070036743
2007-02-15

Antimicrobial polymers

#208
20070025954
2007-02-01

Ionene polymers and their use as antimicrobial agents

#209
20060286174
2006-12-21

Granular sustained release preparation and production thereof

#210
20060286063
2006-12-21

Combination drug therapy for reducing scar tissue formation

#211
20060269480
2006-11-30

Multi-triggered self-immolative dendritic compounds

#212
20060177415
2006-08-10

Once a day formulation for phosphate binders

#213
20060002888
2006-01-05

Polyionenes for treating infections associated with cystic fibrosis

#214
20050266067
2005-12-01

Nanocell drug delivery system

#215
20050137274
2005-06-23

Absorbent articles comprising supercritical fluid treated HIPE, I-HIPE foams and other foams

#216
20050131161
2005-06-16

Process for removing bile salts from a patient and alkylated compositions therefor

#217
20050084514
2005-04-21

Combination drug therapy for reducing scar tissue formation

#218
20050084476
2005-04-21

Preventives and/or remedies for hyperphosphatemia

#219
20050032870
2005-02-10

Use of melanin for inhibition of angiogenesis and macular degeneration